Search

Search Constraints

You searched for: Author/Creator Angenstein, Frank

Search Results

1. AKT1E17K‐mutated meningioma cell lines respond to treatment with the AKT inhibitor AZD5363. (30th December 2021)

2. CBMT-25. THE KLF4K409Q MUTATION IN MENINGIOMA IMPAIRS HIF-1Α DEGRADATION AND CAN BE HARNESSED FOR TARGETED THERAPY. (11th November 2019)

7. Receptor tyrosine kinase inhibition by regorafenib/sorafenib inhibits growth and invasion of meningioma cells. (March 2017)